Risk Stratification in Older Intensively Treated Patients With AML.

Autor: Versluis, Jurjen, Metzner, Marlen, Wang, Ariel, Gradowska, Patrycja, Thomas, Abin, Jakobsen, Niels Asger, Kennedy, Alison, Moore, Rachel, Boertjes, Emma, Vonk, Christian M., Kavelaars, Francois G., Rijken, Melissa, Gilkes, Amanda, Schwab, Claire, Beverloo, H. Berna, Manz, Markus, Visser, Otto, Van Elssen, Catharina H.M.J., de Weerdt, Okke, Tick, Lidwine W.

Publikováno v: Journal of Clinical Oncology; 12/1/2024, Vol. 42 Issue 34, p4084-4094, 13p

AML-464 Advantages and Prognostic Value of Next-Generation Sequencing–Based Mutant NPM1 Measurable Residual Disease Detection in AML

Autor: Vonk, Christian M., Grob, Tim, Rijken, Melissa, Kavelaars, Francois G., Konijnenburg, Jolinda M.L., Löwenberg, Bob, Valk, Peter J.M.

Publikováno v: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S314-S315

Prognostic Value of -Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia.

Autor: Grob, Tim, Sanders, Mathijs A., Vonk, Christian M., Kavelaars, Franҫois G., Rijken, Melissa, Hanekamp, Diana W., Gradowska, Patrycja L., Cloos, Jacqueline, Fløisand, Yngvar, van Marwijk Kooy, Marinus, Manz, Markus G., Ossenkoppele, Gert J., Tick, Lidwine W., Havelange, Violaine, Löwenberg, Bob, Jongen-Lavrencic, Mojca, Valk, Peter J.M.

Publikováno v: Journal of Clinical Oncology; 2/1/2023, Vol. 41 Issue 4, p756-765, 10p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Correction: Lactate dehydrogenase A inhibition by small molecular entities: steps in the right direction.

Autor: El Hassouni B; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands., Franczak M; Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland., Capula M; Fondazione Pisana per la Scienza, Pisa, Italy., Vonk CM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands., Gomez VM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands., Smolenski RT; Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland., Granchi C; Dipartimento di Farmacia, Università di Pisa, Pisa, Italy., Peters GJ; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands.; Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland., Minutolo F; Dipartimento di Farmacia, Università di Pisa, Pisa, Italy., Giovannetti E; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands.; Fondazione Pisana per la Scienza, Pisa, Italy.

Publikováno v: Oncoscience [Oncoscience] 2021 Mar 30; Vol. 8, pp. 46. Date of Electronic Publication: 2021 Mar 30 (Print Publication: 2021).